TRICYCLIC COMPOUNDS
The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using t...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | CLARK, Anthony John KNIGHT, Jennifer Lynn BOS, Pieter Harm WANG, Jiashi GHANAKOTA, Phani PLACZEK, Andrew GERASYUTO, Aleksey Igorevich |
description | The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases such as cancer.
La présente invention concerne des composés de formule (I), tels que définis dans la description, et des sels pharmaceutiquement acceptables de ceux-ci. La présente invention concerne également une composition pharmaceutique comprenant un composé de formule (I), et des sels pharmaceutiquement acceptables de celui-ci, et des procédés d'utilisation des composés et des compositions pour le traitement de maladies telles que le cancer. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024107393A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024107393A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024107393A13</originalsourceid><addsrcrecordid>eNrjZBAOCfJ0jnT28XRWcPb3DfAP9XMJ5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGJoYG5saWxo6GxsSpAgDkDx9m</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TRICYCLIC COMPOUNDS</title><source>esp@cenet</source><creator>CLARK, Anthony John ; KNIGHT, Jennifer Lynn ; BOS, Pieter Harm ; WANG, Jiashi ; GHANAKOTA, Phani ; PLACZEK, Andrew ; GERASYUTO, Aleksey Igorevich</creator><creatorcontrib>CLARK, Anthony John ; KNIGHT, Jennifer Lynn ; BOS, Pieter Harm ; WANG, Jiashi ; GHANAKOTA, Phani ; PLACZEK, Andrew ; GERASYUTO, Aleksey Igorevich</creatorcontrib><description>The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases such as cancer.
La présente invention concerne des composés de formule (I), tels que définis dans la description, et des sels pharmaceutiquement acceptables de ceux-ci. La présente invention concerne également une composition pharmaceutique comprenant un composé de formule (I), et des sels pharmaceutiquement acceptables de celui-ci, et des procédés d'utilisation des composés et des compositions pour le traitement de maladies telles que le cancer.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240523&DB=EPODOC&CC=WO&NR=2024107393A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240523&DB=EPODOC&CC=WO&NR=2024107393A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CLARK, Anthony John</creatorcontrib><creatorcontrib>KNIGHT, Jennifer Lynn</creatorcontrib><creatorcontrib>BOS, Pieter Harm</creatorcontrib><creatorcontrib>WANG, Jiashi</creatorcontrib><creatorcontrib>GHANAKOTA, Phani</creatorcontrib><creatorcontrib>PLACZEK, Andrew</creatorcontrib><creatorcontrib>GERASYUTO, Aleksey Igorevich</creatorcontrib><title>TRICYCLIC COMPOUNDS</title><description>The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases such as cancer.
La présente invention concerne des composés de formule (I), tels que définis dans la description, et des sels pharmaceutiquement acceptables de ceux-ci. La présente invention concerne également une composition pharmaceutique comprenant un composé de formule (I), et des sels pharmaceutiquement acceptables de celui-ci, et des procédés d'utilisation des composés et des compositions pour le traitement de maladies telles que le cancer.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBAOCfJ0jnT28XRWcPb3DfAP9XMJ5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGJoYG5saWxo6GxsSpAgDkDx9m</recordid><startdate>20240523</startdate><enddate>20240523</enddate><creator>CLARK, Anthony John</creator><creator>KNIGHT, Jennifer Lynn</creator><creator>BOS, Pieter Harm</creator><creator>WANG, Jiashi</creator><creator>GHANAKOTA, Phani</creator><creator>PLACZEK, Andrew</creator><creator>GERASYUTO, Aleksey Igorevich</creator><scope>EVB</scope></search><sort><creationdate>20240523</creationdate><title>TRICYCLIC COMPOUNDS</title><author>CLARK, Anthony John ; KNIGHT, Jennifer Lynn ; BOS, Pieter Harm ; WANG, Jiashi ; GHANAKOTA, Phani ; PLACZEK, Andrew ; GERASYUTO, Aleksey Igorevich</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024107393A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CLARK, Anthony John</creatorcontrib><creatorcontrib>KNIGHT, Jennifer Lynn</creatorcontrib><creatorcontrib>BOS, Pieter Harm</creatorcontrib><creatorcontrib>WANG, Jiashi</creatorcontrib><creatorcontrib>GHANAKOTA, Phani</creatorcontrib><creatorcontrib>PLACZEK, Andrew</creatorcontrib><creatorcontrib>GERASYUTO, Aleksey Igorevich</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CLARK, Anthony John</au><au>KNIGHT, Jennifer Lynn</au><au>BOS, Pieter Harm</au><au>WANG, Jiashi</au><au>GHANAKOTA, Phani</au><au>PLACZEK, Andrew</au><au>GERASYUTO, Aleksey Igorevich</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TRICYCLIC COMPOUNDS</title><date>2024-05-23</date><risdate>2024</risdate><abstract>The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases such as cancer.
La présente invention concerne des composés de formule (I), tels que définis dans la description, et des sels pharmaceutiquement acceptables de ceux-ci. La présente invention concerne également une composition pharmaceutique comprenant un composé de formule (I), et des sels pharmaceutiquement acceptables de celui-ci, et des procédés d'utilisation des composés et des compositions pour le traitement de maladies telles que le cancer.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_WO2024107393A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | TRICYCLIC COMPOUNDS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T02%3A43%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CLARK,%20Anthony%20John&rft.date=2024-05-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024107393A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |